
Jagadishwar Rao Samala
Examiner (ID: 8163, Phone: (571)272-9927 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1215 |
| Issued Applications | 815 |
| Pending Applications | 79 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17207709
[patent_doc_number] => 11168068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Tau PET imaging ligands
[patent_app_type] => utility
[patent_app_number] => 16/318287
[patent_app_country] => US
[patent_app_date] => 2017-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 14
[patent_no_of_words] => 14974
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318287 | Tau PET imaging ligands | Jul 13, 2017 | Issued |
Array
(
[id] => 15355433
[patent_doc_number] => 10526317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Benzocyanine compounds
[patent_app_type] => utility
[patent_app_number] => 15/641376
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 57
[patent_no_of_words] => 71647
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 389
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15641376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/641376 | Benzocyanine compounds | Jul 4, 2017 | Issued |
Array
(
[id] => 11995377
[patent_doc_number] => 20170299530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'COMPOUNDS AND METHODS FOR ANALYSIS AND SYNTHESIS OF SACCHARIDE COMPOUNDS, AND METHOD FOR QUANTITATING SACCHARIDE'
[patent_app_type] => utility
[patent_app_number] => 15/640757
[patent_app_country] => US
[patent_app_date] => 2017-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 44068
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15640757
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/640757 | COMPOUNDS AND METHODS FOR ANALYSIS AND SYNTHESIS OF SACCHARIDE COMPOUNDS, AND METHOD FOR QUANTITATING SACCHARIDE | Jul 2, 2017 | Abandoned |
Array
(
[id] => 14621961
[patent_doc_number] => 20190224348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => Granzyme B Directed Imaging and Therapy
[patent_app_type] => utility
[patent_app_number] => 16/314134
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -101
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314134
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314134 | Granzyme B directed imaging and therapy | Jun 29, 2017 | Issued |
Array
(
[id] => 12580947
[patent_doc_number] => 20180085478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) BIOLOGICAL EVALUATION, AND USE OF IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/639445
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15639445
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/639445 | Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents | Jun 29, 2017 | Issued |
Array
(
[id] => 14744049
[patent_doc_number] => 20190255198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => Half-Curcuminoids as Amyloid-Beta PET Imaging Agents
[patent_app_type] => utility
[patent_app_number] => 16/314153
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314153 | Half-curcuminoids as amyloid-beta PET imaging agents | Jun 28, 2017 | Issued |
Array
(
[id] => 17353055
[patent_doc_number] => 11227699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Method for producing a fraction of Xenon radioisotopes, in particular Xe-133, fraction of Xenon radioisotopes, in particular Xe-133
[patent_app_type] => utility
[patent_app_number] => 16/312192
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3397
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312192
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312192 | Method for producing a fraction of Xenon radioisotopes, in particular Xe-133, fraction of Xenon radioisotopes, in particular Xe-133 | Jun 27, 2017 | Issued |
Array
(
[id] => 14631003
[patent_doc_number] => 20190228870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => METHOD FOR PRODUCING AN IODINE RADIOISOTOPES FRACTION, IN PARTICULAR OF I-131, IODINE RADIOISOTOPES FRACTION, IN PARTICULAR OF I-131
[patent_app_type] => utility
[patent_app_number] => 16/312963
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312963 | Method for producing an iodine radioisotopes fraction, in particular of I-131, iodine radioisotopes fraction, in particular of I-131 | Jun 27, 2017 | Issued |
Array
(
[id] => 16475074
[patent_doc_number] => 10849994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Pharmaceutical composition comprising fluorine-18 labelled gases
[patent_app_type] => utility
[patent_app_number] => 16/310723
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 7951
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310723
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310723 | Pharmaceutical composition comprising fluorine-18 labelled gases | Jun 26, 2017 | Issued |
Array
(
[id] => 16696617
[patent_doc_number] => 10947197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [
[patent_app_type] => utility
[patent_app_number] => 16/308128
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14634
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308128 | Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [ | Jun 8, 2017 | Issued |
Array
(
[id] => 12057235
[patent_doc_number] => 20170333579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'COMPOSITIONS AND ASSOCIATED METHODS FOR RADIOISOTOPE-BINDING MICROPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 15/615586
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14045
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615586
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/615586 | Compositions and associated methods for radioisotope-binding microparticles | Jun 5, 2017 | Issued |
Array
(
[id] => 12018004
[patent_doc_number] => 09810700
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-11-07
[patent_title] => 'Fluorogenic calcium ion indicators and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 15/610184
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 24324
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15610184
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/610184 | Fluorogenic calcium ion indicators and methods of using the same | May 30, 2017 | Issued |
Array
(
[id] => 14196665
[patent_doc_number] => 10265418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Methods for treating and diagnosing blinding eye diseases
[patent_app_type] => utility
[patent_app_number] => 15/603729
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 40
[patent_no_of_words] => 30736
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603729
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/603729 | Methods for treating and diagnosing blinding eye diseases | May 23, 2017 | Issued |
Array
(
[id] => 18152054
[patent_doc_number] => 11565004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => In vivo imaging of matrix metalloproteinases in lung disease
[patent_app_type] => utility
[patent_app_number] => 16/303599
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 8227
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303599
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303599 | In vivo imaging of matrix metalloproteinases in lung disease | May 18, 2017 | Issued |
Array
(
[id] => 13549107
[patent_doc_number] => 20180326101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TARGETED DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 15/593311
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15593311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/593311 | COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TARGETED DRUG DELIVERY | May 10, 2017 | Abandoned |
Array
(
[id] => 11954792
[patent_doc_number] => 20170258943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Using Heavy Water as a Contrast Agent for Hydrogen Magnetic Resonance Imaging'
[patent_app_type] => utility
[patent_app_number] => 15/591316
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3665
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591316
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591316 | Using Heavy Water as a Contrast Agent for Hydrogen Magnetic Resonance Imaging | May 9, 2017 | Abandoned |
Array
(
[id] => 11935227
[patent_doc_number] => 20170239376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'LABELED EVANS BLUE DYE DERIVATIVE FOR IN VIVO SERUM ALBUMIN LABELING'
[patent_app_type] => utility
[patent_app_number] => 15/587948
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 14403
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/587948 | Labeled evans blue dye derivative for in vivo serum albumin labeling | May 4, 2017 | Issued |
Array
(
[id] => 16634363
[patent_doc_number] => 10912850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/098694
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 17209
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098694
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098694 | None | May 3, 2017 | Issued |
Array
(
[id] => 11992527
[patent_doc_number] => 20170296682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'DERIVATIVES OF DIBENZOTHIOPHENE IMAGING OF alpha-7 NICOTINIC ACETYLCHOLINE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 15/585973
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 37461
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15585973
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/585973 | DERIVATIVES OF DIBENZOTHIOPHENE IMAGING OF alpha-7 NICOTINIC ACETYLCHOLINE RECEPTORS | May 2, 2017 | Abandoned |
Array
(
[id] => 12118754
[patent_doc_number] => 20180002340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'BENZOPYRYLIUM COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/493208
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 31724
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493208
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/493208 | Benzopyrylium compounds | Apr 20, 2017 | Issued |